<i>Runx2</i> and <i>MYC</i> Collaborate in Lymphoma Development by Suppressing Apoptotic and Growth Arrest Pathways <i>In vivo</i>
Karen Blyth(Cancer Research UK Scotland Institute), Ewan R. Cameron(University of Glasgow)
Cited by 101
Related Papers
MCL-1 is a prognostic indicator and drug target in breast cancer
|Cell Death and Disease|2018|202